Search

Your search keyword '"Berg, Christoph P."' showing total 217 results

Search Constraints

Start Over You searched for: Author "Berg, Christoph P." Remove constraint Author: "Berg, Christoph P."
217 results on '"Berg, Christoph P."'

Search Results

6. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients

9. SAT-008 Significance of routinely measured direct alcohol markers in long-term care after liver transplantation

10. THU-457 Outcome of liver transplantation in patients with hepatocellular carcinoma previously treated with immune checkpoint inhibitorbased therapy-first results from an international multicenter registry

13. Treating hepatitis D with bulevirtide – Real-world experience from 114 patients

14. Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure

15. Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis—A real-world case series

17. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

19. A call to caution when hydroxychloroquine is given to elderly patients with COVID-19

20. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

22. Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients

23. Unusual HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients

27. Update fetale Therapie bei kardialen Vitien

28. Treatment strategies for patients with decompensated liver cirrhosis due to hepatitis C virus infection eligible for liver transplantation: real-life data from five German transplant centers

34. A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis

38. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

40. Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial

42. Dynamics of glucose metabolism after liver transplantation: prediabetes as a window of opportunity for patient survival and long‐term kidney function

43. Significance and clinical impact of routinely tested urinary ethyl glucuronide after liver transplantation – development of a risk score

44. Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy

46. Sonographic findings in coronavirus disease-19 associated liver damage

49. Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infection

Catalog

Books, media, physical & digital resources